Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
RecruitingNCT06919432Phase: NAStarted 2025-05-01
Summary
In order to assess the clinical efficacy of triple-daily 15mA-tACS stimulation by comparing the effects of active and sham tACS interventions on driving improvements in adolescent Nonsuicidal Self-Inj
Eligibility
Sex
ALL
Min Age
12 Years
Max Age
21 Years
Locations
Shanghai Mental Health CenterShanghai, Shanghai Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06919432